These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 26275840)
1. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy. Xiao B; Si X; Zhang M; Merlin D Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840 [TBL] [Abstract][Full Text] [Related]
2. Oral Drug Delivery Systems for Ulcerative Colitis Therapy: A Comparative Study with Microparticles and Nanoparticles. Ma P; Si X; Chen Q; Ma L; Hou M; Xu Z; Kang Y; Wang J; Xiao B Curr Cancer Drug Targets; 2019; 19(4):304-311. PubMed ID: 30332962 [TBL] [Abstract][Full Text] [Related]
3. Facile fabrication of bowl-shaped microparticles for oral curcumin delivery to ulcerative colitis tissue. Chen Q; Gou S; Huang Y; Zhou X; Li Q; Han MK; Kang Y; Xiao B Colloids Surf B Biointerfaces; 2018 Sep; 169():92-98. PubMed ID: 29751345 [TBL] [Abstract][Full Text] [Related]
4. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519 [TBL] [Abstract][Full Text] [Related]
5. Porous Polymeric Microparticles as an Oral Drug Platform for Effective Ulcerative Colitis Treatment. Zhou X; Chen Q; Ma Y; Huang Y; Gou S; Xiao B J Pharm Sci; 2019 Jul; 108(7):2238-2242. PubMed ID: 30779888 [TBL] [Abstract][Full Text] [Related]
6. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues. Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012 [TBL] [Abstract][Full Text] [Related]
7. pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model. Gugulothu D; Kulkarni A; Patravale V; Dandekar P J Pharm Sci; 2014 Feb; 103(2):687-96. PubMed ID: 24375287 [TBL] [Abstract][Full Text] [Related]
8. Dual Functional Eudragit Gao C; Yu S; Zhang X; Dang Y; Han DD; Liu X; Han J; Hui M Int J Nanomedicine; 2021; 16():1405-1422. PubMed ID: 33658780 [TBL] [Abstract][Full Text] [Related]
9. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease. Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369 [TBL] [Abstract][Full Text] [Related]
10. Targeting Inflammatory Lesions Facilitated by Galactosylation Modified Delivery System Eudragit/Gal-PLGA@Honokiol for the treatment of Ulcerative Colitis. Wang A; Liu Y; Xiong W; Li W; Li J; Yang Z; Zou Z; Luo Y; Chen Z; Li H; Vong CT; Zou L J Pharm Sci; 2024 Sep; 113(9):2744-2755. PubMed ID: 38901529 [TBL] [Abstract][Full Text] [Related]
12. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis. Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486 [TBL] [Abstract][Full Text] [Related]
13. Oral administration of colitis tissue-accumulating porous nanoparticles for ulcerative colitis therapy. Chen Q; Gou S; Ma P; Song H; Zhou X; Huang Y; Kwon Han M; Wan Y; Kang Y; Xiao B Int J Pharm; 2019 Feb; 557():135-144. PubMed ID: 30594685 [TBL] [Abstract][Full Text] [Related]
14. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics. Zhou X; Liu Y; Wang X; Li X; Xiao B Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717 [TBL] [Abstract][Full Text] [Related]
15. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Krishnamachari Y; Madan P; Lin S Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982 [TBL] [Abstract][Full Text] [Related]
16. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy. Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306 [TBL] [Abstract][Full Text] [Related]
17. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation. Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161 [TBL] [Abstract][Full Text] [Related]
18. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation. Sareen R; Jain N; Rajkumari A; Dhar KL Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141 [TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease. Zeeshan M; Ali H; Khan S; Mukhtar M; Khan MI; Arshad M Nanomedicine (Lond); 2019 Aug; 14(15):1945-1969. PubMed ID: 31355705 [No Abstract] [Full Text] [Related]
20. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice. Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]